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Abstract 
Background/Aim: People with diabetes are at a greater risk of serious complications from Coronavirus disease 
(COVID‑19). Self‑management of diabetes is therefore of paramount importance. The purpose of this study is to com‑
pare self‑management of diabetes pre‑COVID‑19 and during the COVID‑19 pandemic.
Methods: 679 participants with diabetes completed an online structured questionnaire survey. Various exposure 
variables (demographics, duration, treatment and complications of diabetes, self‑isolation, etc.) were analysed to 
examine associations with the following outcome variables: (i) fluctuation of blood glucose levels, (ii) access to 
diabetes medicine, (iii) access to healthy diet, (iv) physical activity. Adjusted multiple regression analysis ascertained 
significant associations for each outcome variable against exposure variables.
Results: Multiple regression analysis showed that self‑isolation was significantly associated with greater fluctua‑
tion in blood glucose levels (OR = 1.8, 95% CI = 1.2–2.6, p = 0.005), reduced access to diabetes medicine (OR = 1.9, 
95% CI = 1.1–3.1, p = 0.02) and reduced access to healthy diet (OR = 3.0, 95% CI = 2.0–4.6, p < 0.001). Fluctuation in 
blood glucose level was also significantly associated with having at least one complication of diabetes (OR = 2.2, 95% 
CI = 1.2–3.9, p = 0.008) and reduced access to diabetes medicine was significantly higher in people who were on 
insulin (OR = 2.1, 95% CI = 1.3–3.3, p = 0.001).
Conclusions: Self‑isolation was shown to impact almost all factors that influence self‑management of diabetes. A 
targeted approach to improved access to diabetes medicine, healthy diet for people who needed to self‑isolate is vital 
in order to ensure that they are able to self‑manage their diabetes effectively.
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Introduction
Since the coronavirus disease was first identified in 
Wuhan, Hubei province of China in 2019 (named as 
COVID-19 by the World Health Organisation [WHO], 
on 11 February 2020), its spread around the world at an 
alarming rate forced the WHO to declare it as a global 
health emergency in just within two and half months 
(on March 11, 2020) from its first detection. So far (as of 
September 29, 2021), more than 232 million people have 
been infected by COVID-19 worldwide with over 4.7 mil-
lion mortalities [1].
The pandemic has affected the lives and livelihood of 
millions of people forcing them to suddenly adapt to a 
‘new normal’ way of living. Amongst the changes brought 
about by the COVID-19 pandemic include the require-
ment to wear facemasks, frequent washing of hands, the 
need to maintain safe physical distance from each other, 
having to minimise non-essential travel/contact, etc. Fur-
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restrictions in movement and ban on the social gather-
ing, closure of shops, sporting venues, leisure parks and 
praying venues, shortage of food supplies and panic 
buying. The pandemic also has a negative impact on the 
mental wellness of people as a result of worry around fear 
of job losses, the possibility of being infected with coro-
navirus, etc. Changes due to pandemic also included hav-
ing to work remotely and an increased sedentary lifestyle. 
In addition, self-isolation is a requirement if infected with 
COVID-19 or someone living with has tested positive for 
COVID-19. All these changes can impact upon people’s 
access to medicine, physical activity, healthy diet and 
health services including cancellation or postponement 
of non-urgent appointments [2], leading to poor control 
of non-communicable disease including diabetes [3–9].
People with underlying diseases such as diabetes are 
at an increased risk of severe illness and mortality from 
the COVID-19 infection. A recent meta-analysis of 33 
studies found that people with diabetes were 2.7 times 
more likely to develop severe illness following COVID-
19 infection and 1.9 times more likely to die from it 
compared to those without diabetes [10]. It is therefore 
important that people with diabetes are able to moni-
tor blood glucose levels regularly, attend doctor/hospi-
tal appointments, access the right kind of medicine, be 
physically active and eat healthy food [11]. Research also 
suggests that active and proper self-management reduces 
the risk of serious complications of diabetes by 53–63% 
and the risk of mortality by 46% [12, 13] as people self-
manage their diabetes over 95% of the time [14].
Recent research on people with diabetes has shown 
increased consumption of carbohydrate and sugary 
foods, decreased physical activity, reduced self-mon-
itoring of blood glucose levels and increased stress and 
anxiety during the pandemic [15–19]. On comparing 
pre-pandemic and during pandemic states, studies have 
shown greater fluctuation in blood glucose levels in 
patients with diabetes [20], worsening of complications 
of diabetes [21] and higher blood glucose levels in newly 
diagnosed patients [22]; factors associated with these 
changes are not well understood. On the other hand, 
studies from India and Poland have reported a positive 
effect on people’s behaviour and blood glucose levels dur-
ing the pandemic including more consumption of fruits, 
vegetables and nutritious/regular meals [15, 23]. A study 
from Italy reported that blood glucose levels improved 
during the first seven days of stopping to work suggesting 
that slowing down of daily routine might have a benefi-
cial effect (at least in the short-term) on diabetes control 
[24].
A number of studies have examined the effect of 
COVID lockdown on diabetes self-management [25–28]. 
These studies found that blood glucose levels fluctuated 
more during the COVID lockdown and were associated 
with poor diet, increased anxiety and reduced physical 
activity levels. Various interventions were suggested such 
as increased physical activity at home [27, 28] and eating 
more vegetables [27] to improve blood glucose levels dur-
ing the lockdown. However, how different factors includ-
ing (but not limited to) the mandatory need to self-isolate 
(with strict domiciliary confinements) because someone 
(or a person living with) was infected with COVID-19, 
duration of self-isolation, age, gender, duration, treat-
ment and complications of diabetes are associated with 
diabetes self-management during the COVID pandemic 
is not well known. Needing to self-isolate means people 
are strictly not able to go out of their homes, as a con-
sequence of which their basic outdoor activities such as 
walking, running, cycling, going to the doctor/pharmacy 
to get medicine and buying healthy foods are likely to get 
worsened compared to those who did not need to self-
isolate as they could still go out of their homes for these 
basic outdoor activities. These (above) factors, together 
with anxiety about underlying health (e.g., diabetes) and 
loneliness because of not being able to socialise face-
to-face with friends and relatives may put people with 
diabetes who needed to self-isolate mandatorily (due 
to COVID-19 infection or coming in close contact with 
someone who was infected with COVID-19) at a higher 
risk of poor diabetes self-management and uncontrolled 
diabetes, which was investigated in this study. Such as 
investigation is needed in order that evidence-led guide-
line development for improved diabetes self-management 
by targeting those risk factors significantly associated 
with poor diabetes self-management during (or specific 
to) the COVID-19 pandemic is possible.
Methodology
Study aim
To examine how various exposure factors including 
demographic characteristics (age, gender), duration, 
treatment and complications of diabetes, the need to 
self-isolate (due to being infected or coming in contact 
with someone infected with COVID-19) and duration 
of self-isolation (see Table 1), were associated with the 
following outcomes of diabetes self-management: (i) 
fluctuation of blood glucose levels; (ii) reduced access 
to diabetes medicine; (iii) reduced access to right kind 
of food for diabetes; and (iv) reduced physical activity.
Study design and setting
A cross-sectional online survey carried out between 
May 2020 and November 2020.
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Survey material
A structured questionnaire built on an existing validated 
diabetes self-management questionnaire [29], and previ-
ous literature on factors that may affect the management 
of diabetes including demographics, history of diabetes 
(duration/treatment and any long-term complications 
such as retinopathy, neuropathy, nephropathy), access 
to diabetes medicine, fluctuation in blood glucose lev-
els, access to a healthy diet, and physical activity [8, 9]. 
Questions around COVID-19 such as whether partici-
pants had experienced symptoms or tested positive for 
COVID-19 by a standard Polymerase Chain Reaction 
(PCR) test, whether they needed to self-isolate, etc., were 
adapted from the previous studies [30, 31]. All questions 
were reviewed and agreed upon by authors (SP and RS) 
who are experienced in conducting survey-based studies 
[8, 9, 30], which were then pretested/validated on a small 
sample of people with diabetes (n = 20) who were not 
included in this study.
Power analysis
With a 12% prevalence rate of diabetes in the adult popu-
lation [31], precision error of 5% and type 1 (α) error of 
5%, the required sample size was calculated to be 676. 
Our sample size exceeds this number.
Study participants
A total of 679 participants (UK, Bangladesh, India and 
Nepal, 52% male) above 18  years of age (median age 
range: 50–60  years) who self-reported to have diabe-
tes (of any type) completed the survey. Work from our 
laboratory has shown that not all our participants are 
aware of the type of diabetes they have [9] so we asked 
them to comment on whether they were on insulin 
treatment or not which we consider to be more appro-
priate for the aims of this study (30.4% of the total partic-
ipants reported being on insulin or combined treatment, 
Table 1). Also, we did not ask for information about ges-
tational diabetes or maturity onset diabetes of the young 
(MODY), which is caused by a gene mutation.
Participants were treated in accordance with appli-
cable ethical guidelines that followed the tenets of the 
Helsinki Declaration. Information that could identify 
individual participant during or after data collection 
were not recorded. The study protocol was approved by 
Anglia Ruskin University’s Faculty of Health, Education, 
Medicine and Social Care Research Ethics Panel [ref. no.: 
19/20/024].
Procedure
Participants were invited to take part in the study 
through social media (Facebook, WhatsApp), online 
adverts, word of mouth, or contacts through acquaint-
ances. Participants were informed at the beginning (i.e., 
before the survey began) about the purpose of the study 
and were provided with information about their ano-
nymity and confidentiality. Participants were allowed to 
complete the survey only once and exit it at any time, 
but if exited without clicking the ‘submit’ button their 
responses were not saved. They were required to com-
plete the entire survey in a single session which lasted 
for approximately 8–10  min. All the questions needed 
a response before the ‘submit’ button could be enabled. 
Where participants were not able to complete the survey 
Table 1 Demographics with participant numbers and percentages for different exposure variables
Variable Categories Number (%)
Age group  < 50 years 265 (39%)
50 years or above 414 (61%)
Gender Male 354 (52.1%)
Female 325 (47.9%)
Duration of diabetes Up to 5 years 294 (43.3%)
 > 5 years 385 (56.7%)
Having diabetes complications like retinopathy Yes 58 (8.6%)
No 617 (91.4%)
Diabetic Treatment Insulin/combined 204 (30.4%)
Non‑insulin 466 (69.6%)
Needing to self‑isolate mandatorily Yes 140 (20.6%)
No/prefer not say 539 (79.4%)
Duration of self‑isolation Up to one week 53 (37.9)
Over one week 82 (62.1%)
Tested positive for COVID‑19 by a standard test Yes 55 (17.1%)
No 266 (82.9%)
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themselves (for example, due to being computer illiter-
ate), responses were either collected via telephone inter-
views by a member of the research team in local language 
or participants could ask their literate family members to 
complete the survey on their behalf. No face-to-face data 
collection was performed to avoid the risk of COVID-19 
infection or transmission.
All survey responses were anonymous. Participant’s 
responses across questions could vary from ‘yes’, ‘no’, ‘not 
sure’, ‘not applicable’, ‘prefer not to say’ etc. The responses 
were relabelled afterwards into binary forms, e.g., ‘yes’, 
‘no/not sure’. Responses like ‘not applicable’ (for example 
to a specific question, ‘did you have to self-isolate because 
you tested positive for COVID-19 or had COVID-19 like 
symptoms?’) were not included in the analyses. Guide-
lines for conducting survey studies were followed [32].
Exposure and outcome variables were categorised as 
per the aims of our study and analyses were carried out 
appropriately. Associations between exposure variables 
(age, gender, duration of diabetes and type of treatment, 
known complications of diabetes, and the need for man-
datory self-isolation) and each outcome variable (fluctua-
tion of blood glucose levels, change in access to diabetes 
medicine and healthy diet, and change in physical activ-
ity) was examined.
Data analysis
Bivariate analysis (Chi-square, Fisher’s exact test) exam-
ined associations between each exposure and the out-
come variable. Significant variables were then fitted into 
a multivariate logistic regression. Test of multicollinear-
ity was performed for categorical variables, and where 
the exposure variables were highly correlated (e.g., need 
to self-isolate, testing positive for COVID-19) only one 
variable was used in the multivariate logistic regression 
analysis.
Results
Out of all the 679 participants, as Table  1 shows, 52% 
were males, over 61% were ≥ 50  years of age, 57% 
reported having diabetes for more than 5 years and 8.6% 
reported they had developed at least one form of long-
term complications of diabetes such as the retinopathy. 
Of the total, 30.4% were on insulin treatment, 20.6% 
(n = 140) needed to self-isolate because of the COVID-19 
infection in themselves or someone living with or experi-
encing COVID-19 like symptoms such as fever, persistent 
cough, difficulty breathing and loss of taste and smell. 
COVID-19 symptoms lasted for more than one week in 
62.1% of those who needed to self-isolate.
Rest of the ‘Results’ focus on identifying factors that 
were associated with different outcomes important for 
diabetes self-management (A-D, below) during (specific 
to) the COVID-19 pandemic compared to pre-pandemic.
Greater fluctuation of blood glucose levels
A total of 242 (35.6%) participants reported that their 
blood glucose levels fluctuated more during the COVID 
pandemic compared to the pre-pandemic. Table  2A 
shows Chi-square results for various exposure variables 
associated with the greater fluctuation of blood glucose 
levels during the pandemic.
Multivariate logistic regression showed a greater fluc-
tuation in blood glucose levels was significantly asso-
ciated with the need to self-isolate (OR = 1.8, 95% 
CI = 1.2–2.6, p = 0.005) (Table  2B) and also with the 
presence of at least one form of long-term complica-
tion of diabetes such as the retinopathy, neuropathy and 
nephropathy (OR = 2.2, 95% CI = 1.2–3.9, p = 0.008).
Reduced access to diabetes medicine
A total of 94 (13.8%) participants reported their access to 
diabetes medicine got worse during the pandemic com-
pared to the pre-pandemic. Table  3A shows Chi-square 
results for various exposure variables associated with 
reduced access to diabetes medicine during the pan-
demic (compared to pre-pandemic).
Multivariate logistic regression showed reduced access 
to diabetes medicine was significantly associated with the 
need to self-isolate (OR = 1.9, 95% CI = 1.1–3.1, p = 0. 02) 
(Table  3B) and the use of insulin treatment (OR = 2.1, 
95% CI = 1.3–3.3, p = 0.001).
Reduced access to right kind of food
A total of 142 (20.9%) participants reported that their 
access to the right kind of food suggested for good dia-
betes control reduced during the pandemic compared 
to pre-pandemic. Table  4A shows Chi-square results 
for various exposure variables associated with the 
reduced access to healthy food recommended for good 
diabetes control during the pandemic (compared to 
pre-pandemic).
Multivariate logistic regression showed that reduced 
access to healthy food recommended for good diabetes 
control was significantly associated with the need to self-
isolate (OR = 3.0, 95% CI = 2.0–4.6, p < 0.001) (Table 4B).
Reduced physical activity
A total of 308 (45.4%) participants reported that their 
overall physical activity reduced during the pandemic 
compared to pre-pandemic. Table  5 shows Chi-square 
results for various exposure variables associated with 
reduced physical activity during the pandemic (com-
pared to pre-pandemic). None of the exposure variables 
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was found to be significantly associated with the outcome 
variable of reduced physical activity.
The outcome variables provided in Table  2 (fluctua-
tion in blood sugar levels) and Table  3 (access to dia-
betic medicine) are not strictly the self-care behaviors. 
Nonetheless, the inclusion of these variables respectively 
provided reflection of whether diabetes was adequately 
monitored and controlled, and the patients’ compliance 
with diabetes medication, which are important self-care 
behaviors [33].
Discussion and conclusion
Diabetes is one of the most commonly reported comor-
bidities in people infected with COVID-19 [34–36]. At 
a time when access to health care facilities is severely 
limited owing to lockdown/quarantine measures and 
cancellation or postponement of routine/non-urgent 
appointments, it has become more important than ever 
before to examine how various factors influence diabetes 
self-management during the COVID-19 pandemic. Lim-
ited access to medicine and healthcare professionals, 
fresh food, physical activity, and increased stress and 
anxiety have been identified as common barriers to good 
diabetic control during the COVID pandemic [15, 25–28, 
37]. In this study, we extend and show how other factors 
including the need to self-isolate, duration of self-isola-
tion, age, gender, duration, treatment and complications 
of diabetes are associated with diabetes self-management 
during the COVID pandemic so that specific barriers to 
improved diabetes self-management can be targeted.
The prevalence of COVID-19 infection (confirmed 
by a standard PCR test) was found to be 8.1% in all our 
participants agreeing with previous studies which have 
reported rates of 8–10% in people with diabetes in the 
community [38, 39]. However, among patients hospital-
ized with COVID-19, a much higher prevalence (19%) of 
diabetes has been reported [40].
Table 2 Fluctuation of blood glucose levels
A Chi-square tests showing association of various exposure variables with the outcome variable of greater fluctuation of blood glucose levels during the pandemic 
compared to pre-pandemic. *represent significant p-values. B Adjusted Multivariate Logistic Regression results showing needing to self-isolate and presence of 
diabetes complications as significant factors associated with greater fluctuation of blood glucose levels during the pandemic compared to pre-pandemic
A
Outcome variable (Greater fluctuation of blood 
sugar levels) response category
P-value
Exposure variable Exposure variable response category Yes No/not sure
Age group  < 50 years 105 (38.9%) 165 (61.1%) 0.93
50 years or above 137 (38.3%) 221 (61.7%)
Gender Male 126 (38.9%) 198 (61.1%) 0.87
Female 116 (38.2%) 188 (61.8%)
Duration of diabetes Up to 5 years 105 (38.9%) 165 (61.1%) 0.47
 > 5 years 137 (38.3%) 221 (61.7%)
Treatment of diabetes Non‑insulin 161 (36.6%) 279 (63.4%) 0.07
Insulin/combined 80 (43.5%) 105 (56.5%)
Presence of diabetes complications like 
retinopathy
Yes 30 (56.6%) 23 (43.4%) 0.005*
No/not sure 189 (36.9%) 323 (63.1%)
Needing self‑isolation Yes 65 (50.0%) 65 (50.0%) 0.003*
No/prefer not say 177 (35.5%) 321 (64.5%)
Duration of self‑isolation Up to one week 26 (48.1%) 25 (51.9%) 0.44
More than one week 38 (48.1%) 41 (51.9%)
B
Exposure variable Exposure variable category Association with greater fluctuation of blood 
sugar levels
P-value
Odds Ratio (95% CI)
Presence of diabetes complications like 
retinopathy
Yes 2.18 (1.23–3.87) 0.008*
No/not sure (Reference)
Needing to self‑isolate Yes 1.76 (1.18–2.61) 0.005*
No/prefer not say (Reference)
Page 6 of 9Pardhan et al. Diabetol Metab Syndr          (2021) 13:123 
In our total sample, 35.6% reported that their blood 
glucose levels fluctuated more during the pandemic. In 
addition, 45.4% of participants reported their physical 
activity reduced during the pandemic. A study from India 
in young adults with type 1 diabetes reported deteriora-
tion of blood glucose levels in 72% of people and reduced 
physical activity in 90% of people during the pandemic 
[41]. Our study agrees with that of Khare and Jindal [26], 
who reported worsening of blood glucose level in 39.2% 
of diabetes patients although it was not clear what pro-
portion of these patients were self-isolating.
Needing to self-isolate was found to be the single most 
important factor influencing all (but reduced physi-
cal activity) variables investigated in our study that have 
the potential to influence diabetes self-management. 
The likelihood of fluctuation in blood glucose levels 
was nearly two times higher (OR = 1.8, 95%, p = 0.005, 
CI = 1.2–2.6) in those who needed to self-isolate com-
pared to those who did not need to self-isolate, and over 
two times higher (OR = 2.2, 95%, p = 0.008, CI = 1.2–3.9) 
in those who had diabetes complications compared to 
those who did not.
Self-isolation was significantly associated with reduced 
access to diabetes medicine during the pandemic with 
odds ratio of nearly two times higher (OR = 1.9, 95%, 
p = 0.02, CI = 1.1–3.1) in those who needed to self-iso-
late compared to those who did not. In addition, those 
who were on insulin treatment were over two times 
more likely to have reduced access to diabetes medicine 
(OR = 2.1, 95%, p = 0.001, CI = 1.3–3.3) compared to 
those who were not on insulin treatment.
Our study adds to the literature in that we show that 
self-isolation was also significantly associated with 
reduced access to healthy food and diabetes medicine. 
A qualitative study from Wuhan, China in patients with 
Type 2 diabetes (n = 12) who had to self-isolate after 
being discharged from the hospital for COVID infection 
identified barriers such as shortage of physical spaces and 
resources (food, medicine) to be the key factors hinder-
ing diabetes self-management [25].
Table 3 Reduced access to diabetes medicine
A Chi-square results showing association of various exposure variables with the outcome variable of reduced access to diabetes medicine during the pandemic 
compared to pre-pandemic. *represent significant p-values. B Adjusted Multivariate Logistic Regression results showing needing to self-isolate and being on insulin 
treatment are associated significantly with reduced access to diabetes medicine during the pandemic compared to pre-pandemic
A
Outcome variable (Reduced access to diabetes 
medicine) response category
P-value
Exposure variable Exposure variable category Yes No/not sure
Age group  < 50 years 35 (17.2%) 168 (82.8%) 0.99
50 years or above 59 (17.4%) 281 (82.6%)
Gender Male 48 (16.8%) 237 (83.2%) 0.82
Female 46 (17.8%) 212 (82.2%)
Duration of diabetes Up to 5 years 36 (17.0%) 176 (83.0%) 0.91
 > 5 years 58 (17.5%) 273 (82.5%)
Treatment of diabetes Non‑insulin 48 (13.4%) 310 (86.6%) 0.001*
Insulin/combined 46 (25.0%) 138 (75.0%)
Presence of diabetes complications like 
retinopathy
Yes 14 (26.9%) 38 (73.1%) 0.08
No/not sure 79 (16.2%) 409 (83.8%)
Needing to self‑isolate Yes 28 (25.5%) 82 (74.5%) 0.02*
No/prefer not say 66 (15.2%) 367 (84.8%)
Duration of self‑isolation Up to 1 week 8 (21.1%) 30 (78.9%) 0.64
More than 1 week 19 (26.0%) 54 (74.0%)
B
Exposure variable Exposure variable category Association with reduced access to diabetes 
medicine
P-value
Odds Ratio (95% CI)
Treatment of diabetes Insulin or combined 2.13 (1.35–3.35) 0.001*
Non‑insulin (Reference)
Needing to self‑isolate Yes 1.86 (1.11–3.09) 0.02*
No/prefer not say (Reference)
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It was somewhat surprising that none of the expo-
sure variables, and in particular those who needed self-
isolation, were found to be significantly associated with 
reduced physical activity during the COVID-19 pan-
demic. This may be because living either under total or 
partial lockdown at the time of the survey could have 
limited the overall outdoor physical activities for most 
participants and not just for those who needed to self-
isolate [18, 27].
Self-management of diabetes involves many more 
activities (foot care, smoking, adherence to medica-
tions, stress management, keeping review dates, etc.) 
in addition to the parameters we have examined. Inclu-
sion of those parameters would have made the study 
more comprehensive and can be included in a future 
study. Also, our study compared self-reported data 
before and during the pandemic. This retrospective 
judgement could have been influenced by differences in 
bias and memory recall abilities. However, the only way 
around that would have been to collect the data before 
the pandemic began which was not possible.
While some earlier studies have reported the posi-
tive effect of COVID pandemic on behavior of diabe-
tes people such as increased consumption of fruits and 
vegetables [23] and increased motivation for home 
exercise [42], several other studies have shown that 
access to healthy diet and physical exercises in diabetes 
people deteriorated significantly during the COVID-
19 pandemic [15–18]. Our data show that people with 
diabetes who are required to self-isolate are at a higher 
odds of poor diabetes self-management (as a result of 
reduced access to healthy food and diabetes medicine) 
and uncontrolled diabetes, and need more informed 
self-management guidelines in order to enable better 
self-management. In addition, our data also show the 
need for having improved access to diabetes medicine 
in those who are on insulin treatment, and increased 
awareness about self-monitoring of glucose levels in 
Table 4 Reduced access to healthy diet recommended for good diabetes control
A Chi-square results showing association of various exposure variables with the outcome variable of reduced access to healthy food for good diabetic control during 
the pandemic compared to pre-pandemic. *represent significant (or near significant) p-values. B Adjusted Multivariate Logistic Regression results showing needing to 
self-isolate is associated significantly with reduced access to healthy food during the pandemic compared to pre-pandemic
A
Outcome variable (Reduced access to healthy 
diet) response category
P-value
Exposure variable Exposure variable category Yes No/not sure
Age group  < 50 years 54 (21.8%) 194 (78.2%) 0.77
50 years or above 88 (22.9%) 297 (77.1%)
Gender Male 68 (20.7%) 261 (79.3%) 0.29
Female 74 (24.3%) 230 (75.7%)
Duration of diabetes Up to 5 years 70 (26.0%) 199 (74.0%) 0.06*
 > 5 years 72 (19.8%) 292 (80.2%)
Treatment of diabetes Non‑insulin 96 (21.7%) 346 (78.3%) 0.53
Insulin/combined 45 (24.2%) 141 (75.8%)
Presence of diabetes complications like 
retinopathy
Yes 13 (24.5%) 40 (75.5%) 0.73
No/not sure 128 (22.2%) 448 (77.8%)
Needing to self‑isolate Yes 50 (52.0%) 75 (48.0%)  < 0.001*
No/prefer not say 92 (23.4%) 146 (76.6%)
Duration of self‑isolation Up to one week 25 (53.2%) 22 (46.8%) 0.57
More than one week 33 (42.9%) 44 (57.1%)
B
Exposure variable Exposure variable category Association with reduced access to healthy diet P-value
Odds Ratio (95% CI)
Duration of diabetes Up to 5 years 1.01 (0.68–1.50) 0.6
 > 5 years (Reference)
Needing to self‑isolate Yes 3.01 (1.97–4.60)  < 0.001*
No/prefer not say (Reference)
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people who have complications of diabetes in order to 
prevent further serious complications. Public health 
policies should give priority to those people with dia-
betes who need to isolate because of COVID-19 infec-
tion and also those who have diabetes complications in 
order to ensure that they are able to manage their dia-
betes appropriately during the pandemic.
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